of adenosine in the heart, information is needed on the concentration of adenosine in interstitial fluid, which bathes membrane adenosine receptors on vascular smooth muscle and cardiomyocytes. The effects of blood flow and capillary endothelial cell uptake of adenosine (32) must be accounted for when estimating interstitial concentrations from coronary venous values.
Previously, parameters for capillary endothelial cell transport and consumption of adenosine were determined in the buffer-perfused, isolated guinea pig heart using the multiple-indicator dilution technique (35) . The results demonstrated that although there was a strikingly active endothelial cell uptake and consumption of adenosine, there was still a significant exchange of adenosine between capillary and interstitial regions. Based on these measurements and others, the predicted relation between venous and interstitial adenosine concentrations in the buffer-perfused guinea pig heart was described using a multiple-region mathematical model (26) .
To study adenosine under physiological conditions in the blood-perfused heart, the relation between venous and interstitial adenosine must be determined in vivo. Because coronary flow per gram in buffer-perfused hearts is -10 times higher than in normal bloodperfused hearts, there could be marked differences in adenosine uptake between in vitro and in vivo conditions, and red blood cells may have additional effects. Therefore, the purpose of the present study was to measure capillary endothelial cell transport and consumption of adenosine in the blood-perfused canine heart in vivo, using the multiple-indicator dilution technique and multiple-region model analysis. The goal was to determine the relation between venous and interstitial adenosine concentrations in vivo.
The indicator dilution technique involves simultaneous intracoronary bolus injection of radiolabeled albumin as an intravascular reference, sucrose as an extracellular reference, and adenosine as the permeant compound of interest and measurement of the dilution curves in the coronary venous outflow (24, 29) . Parameter values for capillary transport, exchange, and cellular metabolism were estimated by fitting the dilution curves using a multiple-region mathematical model that describes these processes in a physically realistic fashion (5). The model accounts for the effects of delay and dispersion in nonexchanging conduit vessels (3) and regional flow heterogeneity (21) .
The present results demonstrate a highly active uptake of adenosine by capillary endothelial cells in the blood-perfused dog heart. Only 1% of the tracer adenosine injected into the coronary artery emerged in venous plasma in the form of adenosine under control conditions. Red blood cell uptake was low. Despite the high capillary uptake of tracer adenosine, the predicted steady-state interstitial concentration of endogenous adenosine exceeded the venous concentration by approximately threefold, and interstitial adenosine concentration was estimated to be loo-220 nM in the dog heart.
METHODS

General Preparation
Six mongrel dogs (25-35 kg) of either sex were studied after sedation with morphine sulfate (3 mg/kg SC) and anesthesia with cx-chloralose (100 mg/kg iv), supplemented by 500-mg injections of a-chloralose as needed. The dogs were intubated and mechanically ventilated with a positive-pressure respirator (model 607, Harvard Apparatus, South Natick, MA), which was adjusted to keep end-expiratory CO2 (model LB-2, Beckman Instruments, Fullerton, CA) between 4.5 and 5.5%, and end-expiratory pressure was maintained between 0 and 5 mmHg. Metabolic acidosis secondary to chloralose anesthesia was corrected by intravenous infusion of 1.5% sodium bicarbonate solution via the right femoral vein. A servo-control device (73A, Yellow Springs Instrument) and heating pads kept body temperature near 37°C. Aortic pressure was measured by a strain-gauge manometer (Statham P23 Db, Gould, Cleveland, OH) connected to a polyethylene catheter placed in the aorta via the right femoral artery.
Coronary Artery Cannulation
The left anterior descending coronary artery was cannulated in the closed chest with a stainless steel cannula via the right common carotid artery (verified using fluoroscopy) and perfused with blood from the left femoral artery (Fig. 1) . Before each experiment, the lz51-labeled albumin was passed over a Sephadex (G-25, coarse) chromatographic column to remove possible low-molecular-weight tracer impurities.
[14C] sucrose and [3H] adenosine were evaporated to dryness, resuspended in normal saline containing 1% unlabeled bovine serum albumin, mixed with 12"1-labeled albumin, and drawn into a l-ml tuberculin syringe. Immediately before each injection, an aliquot of the tracer mixture was ejected from the syringe into a glass vial, to which stopping solution was added, to quantify the activity injected. The injectate remaining in the syringe (0.5 ml) was injected into the coronary perfusion cannula.
Experimental Protocols
Capillary uptake of adenosine was assessed under resting control conditions, during intracoronary infusion of nitroglycerin at a rate of 10 nmol/min to study the effects of coronary vasodilation, during intracoronary infusion of the adenosine transport blocker dipyridamole at a rate producing a final concentration of -20 FM, and during intracoronary infusion of iodotubercidin at rates producing final concentrations of -1,3, and 10 FM, to study the effect of inhibiting the enzyme adenosine kinase. A total of six animals were studied, using one of three sequences: resting state -nitroglycerin -dipyridamole (n = 2), resting state -nitroglycerin -iodotubercidin (1 FM) (n = 2), and nitroglycerin -iodotubercidin (3 FM) -iodotubercidin (10 FM) (n = 2). The iodotubercidin concentrations of 1,3, and 10 FM were nominal target values, and the actual plasma concentrations achieved in the experiments were calculated to average 1.7, 4.7, and 14 PM, respectively. 
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The tracers were injected over l-2 s as a well-mixed bolus into the coronary perfusion cannula while coronary sinus blood was sampled.
To maintain constant coronary flow during the tracer measurements, the perfusion pump was changed from constant pressure to constant flow control, at the prevailing coronary flow rate, immediately before each tracer injection.
Nitroglycerin was infused into the cannula for -1 min before switching to constant flow control, because the vasodilator response was rapid, whereas iodotubercidin and dipyridamole were infused for 10 min before switching to constant flow control, because the vasodilator responses appeared more slowly. After each tracer injection, coronary perfusion was returned to constant pressure control for 220 min, until the next tracer injection.
Sample Analysis
Coronary sinus and tracer injectate handling.
Immediately after collection, the samples of coronary sinus blood plus stopping solution were centrifuged at 10,000 rpm for 10 min at 0°C to separate red blood cells. Aliquots of the plasma supernatant (375 ul) were added to 125 ul of ice-cold 4 N perchloric acid (PCA) to precipitate plasma proteins. Preliminary experiments confirmed that this procedure caused the precipitation of at least 98% of 1251-albumin activity in plasma. In selected experiments, the centrifuged red blood cells were set aside for analysis of tritium activity (see Red blood cell uptake). Vials containing the remaining diluted blood samples were weighed to calculate sample volumes. The samples containing PCA were centrifuged for 10 min at 10,000 rpm at 0°C and 350 ul of the acid supernatant was added to 300 ul of a neutralizing solution composed of 4 N KOH and 8 N KsP04. The PCA-insoluble pellets were analyzed for 1251-labeled albumin activity in a gamma well detector (Tracer Northern, Baird, Ortec). The samples of neutralized supernatant were kept ice cold for 30 min after which they were centrifuged for 10 min at 10,000 rpm at 0°C to precipitate excess salt. Supernatant from these samples was stored at -70°C for later analysis.
The tracer injectate reserved for quantification was weighed and added to ice-cold stopping solution containing 1% unlabeled bovine serum albumin. Multiple aliquots were removed for determination of 12"1-labeled albumin activity in the gamma well detector, and aliquots of the remaining injectate were treated identically as the blood samples described above. High-performance liquid chromatography separation. Neutralized plasma extracts were partitioned on a Rainin Microsorb-MV C-18 column (Rainin Instrument, Emeryville, CA) and eluted with a mobile phase consisting of 955% watermethanol for 5 min at a flow rate of 1.0 ml/min, followed by a linear gradient to a final mixture of 80-20% water-methanol after 15 min, using high-performance liquid chromatography (HPLC; Hewlett-Packard model 1090). Column eluant was monitored for light absorbance at a wavelength of 254 nm and the carrier peaks of adenosine, inosine, and hypoxanthine, the retention times of which averaged 13, 9, and 4 min, respectively, were fractionated using a programmable collector (Gilson FC205). The column void volume, collected for 2 min before the hypoxanthine peak, contained [14C] sucrose and tritium assumed to be tritiated water produced in the conversion of hypoxanthine to uric acid. To produce similar quench for liquid scintillation counting, all the samples were diluted with water to the identical final volume before adding scintillation cocktail (ReadySolv HP, Beckman) for dual-label liquid scintillation counting (Beckman Instruments LS 5801). Beta activities in all samples were corrected for background activity and spillover of 14C activity into the 3H window for the void volume samples.
Red Blood Cell Uptake of Pacer Adenosine In Vivo
In two selected experiments, red blood cells from samples of coronary sinus blood and stopping solution collected 2-6 s after the peak of the curves were washed twice in ice-cold stopping solution and divided into halves. One half of each sample was analyzed for 12"I-labeled albumin activity to quantify the residual plasma content, and the other half was lysed with 125 ul of 4 N PCA. Samples were centrifuged and neutralized, and aliquots (100 ml) of the supernatant were added to 15 ml of scintillation cocktail and analyzed for "H activity in the liquid scintillation detector.
Calculation of Dilution Curves
Dilution curves, normalized to the injected activity, were calculated using the expression h(t) = FC(t)/qO, where h(t) is the fraction of injected tracer collected in the coronary venous samples per second, F is the rate of coronary flow (ml/s) during the measurement, C(t) is the tracer activity in the samples of coronary venous plasma (cpm/ml) at time t after the tracer injection, and q. is the activity (cpm) injected in the bolus (5).
Model Validation:
Nontracer Adenosine Infusions
In five additional animals, the left main coronary artery was cannulated in the closed chest, using the protocol described above, and perfused at a constant pressure of 100 mmHg. After baseline hemodynamic measurements, samples of arterial and coronary venous blood were withdrawn into syringes while rapidly mixing with ice-cold enzymatic stopping solution, using procedures described previously (19). Adenosine at a concentration of 0.1 or 1.0 mM was infused at a series of constant rates into the coronary perfusion cannula to produce steady-state increases in coronary blood flow. Coronary arterial and venous blood samples were withdrawn at five or six levels of adenosine infusion while flow was measured simultaneously.
Plasma adenosine concentrations were measured in neutralized PCA extracts using an adenosine deaminase peakshift HPLC technique, similar to a method described earlier U9). estimated during fitting of the sucrose curve, to make up for possible small systematic differences in quantifying albumin relative to sucrose and adenosine, because the latter tracers were analyzed using quite different procedures.
Chemicals and Solutions
The scaling coefficient averaged 0.96 t 0.37, 0.89 t 0.17, 0.84 5 0.16, and 1.18 ZL 0.01 for control, nitroglycerin, iodotubercidin, and dipyridamole conditions, respectively. A value of 1.0 indicates perfect quantification.
Adenosine curve. The values of PS, and V&-obtained by fitting the sucrose curve were used to fit the adenosine curve, except that PS, for adenosine was increased by 13%, using the approximation MW,,,/MW,d, (34), where MW is the respective molecular weight, to account for the difference in aqueous diffusion coefficients between sucrose and adenosine. The input scaler estimated from the sucrose curve was used to scale the input function for adenosine. The model parameters describing cellular membrane transport (P&l and PS,,) and consumption (G,, and G,,) were estimated by fitting the adenosine dilution curves with the use of the optimizer and applying the input function and vascular parameters obtained by fitting the albumin curve. The parameter that describes transport across the abluminal endothelial cell membrane (PS,,,), was constrained to equal the parameter that describes luminal membrane transport (P&J, because the sensitivity for PS,,, was too low to permit independent identification. Volumes of endothelial (Vk,) and parenchymal (Vbc) cells were constrained to anatomic values of 0.03 (1) and 0.6 ml/g, respectively, and were not varied in the fitting. To fit the early peak of the adenosine curves under control conditions, two additional parameters were estimated that describe flow heterogeneity in the multiple-pathway model (see Flow Heterogeneity).
Altogether, six parameters were simultaneously adjusted to fit the control adenosine curves. To fit the adenosine curves under all other experimental conditions, only the four membrane transport and consumption parameters (P&l, PSpc, G,,, and G,,) were adjusted, because the importance of the two heterogeneity parameters was greatly reduced due to elevated flow rates.
Optimization Procedures
All model parameter estimates were obtained using a weighted nonlinear least squares optimizer routine, based on sensitivity functions (9). To fit the dilution curves, the optimizer adjusts the parameter values, beginning with a set of starting values. To reduce possible bias in the final parameter estimates due to the choice of starting values, each adenosine curve was independently fit 25 times using randomized starting values for the parameters to be optimized. The means and standard deviations of the parameter estimates from the 25 replicate fits were reported as the final parameter values for each curve. In this way, possible bias due to starting values was averaged out. Randomized starting values of the parameters were also used for the Monte Carlo simulations (see APPENDIX) . To evaluate the model fits, the coefficient of variation (CV) was used
where yi is the value of the ith data point in the dilution curve, $ is the corresponding model solution, and N is the number of data points in the curve.
Flow Heterogeneity
To model the effects of regional flow heterogeneity on the tracer kinetics, the model is composed of 20 parallel capillary pathways, identical except for their flow. Flow was apportioned among the parallel pathways to represent the myocardial flow distribution observed with the use of microspheres (21). In previous modeling of indicator dilution data (24), flow was distributed among the 20 pathways according to a slightly right-skewed lagged normal density function, having a relative dispersion of 55% and weighting the flow in each pathway by a factor representing the fraction of tissue receiving that flow (5). The weighted mean flow in the model was equal to the measured plasma flow during each tracer experiment.
However, in the present experiments, this distribution did not adequately represent the contribution of the highest-flow pathways needed to fit the upslope of the adenosine dilution curves obtained under control conditions. Therefore, the two heterogeneity parameters for the highest-flow pathway (relative flow and weight) were increased to better values using the optimizer, together with the four parameters describing cellular transport and metabolism during the fitting of the control adenosine curves. This adjustment had negligible effect on the albumin and sucrose curves, because the flow passing through the highest-flow pathway averaged less than 0.1% of the total flow through all the pathways, and capillary uptake was negligible compared with adenosine (see APPENDIX).
To model the flow distribution in the other experimental conditions when coronary flow was increased, the relative dispersion of the lagged normal density function describing flow heterogeneity was decreased to 45% and the highest-flow pathway was given its normal flow and weight based on the density function, to account for the decrease in heterogeneity that has been observed during coronary vasodilation (10,17).
Modeling Nontracer Adenosine
The validity of the model for nontracer adenosine was tested by comparing predicted venous concentrations with venous measurements obtained during intracoronary adenosine infusion. To analyze the nontracer adenosine measurements, the model was used to describe steady-state conditions with a constant adenosine production in the cellular regions. It was assumed that adenosine was synthesized in myocardial and endothelial cells at equal rates, expressed per milliliter cell volume, and that the ratio of parenchymal to endothelial cell volumes in the intact tissue was 20:l. The values assigned to the parameters PS,, P&,1, and G,, were equal to the estimates in the tracer studies, adjusted to account for the recruitment of capillary surface area due to increased flow (10). To account for recruitment, the observed linear relation between PS, for sucrose and flow (see RESULTS) was used to obtain values for PS, for adenosine 
where psgo~ psec107 and G,, are the mean values of PS, (0.544 mlminlgl, Table 2 ), $S'ecl (2.87 mlmin'gl, Table 3 ) and G,, (12.6 ml l min.
g-l, Table 3 ) measured under control conditions.
Thus it was assumed that increases in coronary flow caused equivalent fractional increases in PS,, PS,,l, and Ge,. The values of all the regional volumes, as well as PSp, and Gpc, were kept constant at their control levels; they had negligible effect on the relation of venous and interstitial adenosine.
Baseline measurements of venous adenosine concentration were fit exactly by adjusting a single model parameter, cellular production, because flow and arterial adenosine concentration were set to the measured values, PS,, PSecl, and G,, were set according to Eqs. 2-4, and the description of flow heterogeneity was identical to that used for modeling control conditions in the tracer studies (RD = 0.55). During adenosine infusion, venous adenosine concentrations were fit in two ways. In the first approach, no parameters were adjusted to improve the fit of the venous adenosine concentrations. Cellular production was kept at the control value, flow was set to its measured value, arterial adenosine concentration was set to the value determined by the infusion rate and the coronary flow, and PS,, P&,1, and G,, were set according to Eqs. 2-4. Flow heterogeneity for the flow range cl.5 ml*min-l~g-l was modeled exactly as in the control tracer studies (RD = 0.55), whereas heterogeneity was decreased in the flow range 1.5-2.5 ml=minlgl (RD = 0.45) and in the range >2.5 ml=minlgl (RD = 0.35). The second approach was identical to the first, except that the slope of the relation between flow and PS, (recruitment coefficient) was adjusted from the value of 0.202 described in Eq. 2 to give an exact fit of each venous adenosine concentration in the dose-response curve for that individual animal, setting PSecl and G,, using Eqs. 3 and 4. The average value for the recruitment coefficient for each curve was then used to refit all the points of the curve. The purpose of the second approach was to reduce the effects of variability in transport parameter values among animals.
RESULTS
Hemodynamic Measurements
Heart rate, mean arterial blood pressure, coronary perfusion pressure, and myocardial blood flow were in the normal physiological range during the indicator dilution experiments (Table 1) . Nitroglycerin, iodotubercidin, and dipyridamole caused at least fivefold increases in coronary blood flow, compared with control. Coronary flow was held constant at the values in Table  1 during the indicator dilution measurements by temporarily switching the perfusion pump from constant pressure to constant flow control immediately before the tracer injections. Control conditions. Because of the marked uptake and retention of tracer adenosine under control conditions, the adenosine dilution curve was magnified 100 times (Fig. 3, right ordinate) to facilitate the comparison with the reference curves shown with the original scaling of h(t) (fraction of injected indicator emerging in the coronary outflow per second) (Fig. 3, left integral of the adenosine h(t) curve divided by the integral of the sucrose curve (i.e., the normalized recovery) averaged 0.012 5 0.0016 (mean t SD, n = 4). This demonstrates that only 1.2% of the adenosine injected in the tracer bolus appeared in the coronary venous samples in the form of adenosine, relative to sucrose, under control conditions (Fig. 4) . When the activities of all the tritiated compounds in the venous samples were summed, a total of 15 ? 4.1% of the injected adenosine was recovered, relative to sucrose (Fig. 4) . The remaining 85% of the injected adenosine was retained in the heart for the duration of the venous sampling.
A second striking feature observed in each of the control experiments was that the peak of the adenosine curve preceded the peaks of the reference curves by 2-4 s (Fig. 3) . Despite the early appearance of the peak, the adenosine curve remained below those of the reference tracers, even during the early upslope. Although possible causes for this phenomenon include red blood cell --
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carriage and arteriovenous shunt, it was most likely due to regional blood flow heterogeneity, the effects of which were magnified by the high uptake and retention of adenosine. The explanation of heterogeneity was adopted for the modeling because there was evidence against the other possibilities (see Red blood cell uptake). To estimate values of the model parameters R&l, G,,, PS,,, G,, and the two heterogeneity parameters (see METHODS), each adenosine dilution curve was independently fit 25 times using the optimizer routine, by randomizing the starting values of the parameters, to average out possible optimizer bias (see METHODS). Means and SD of the 25 replicate estimates of the endothelial cell parameters PSecl and G,, are shown for each experiment in Fig. 5 , and the overall averages for P9 A ecl9 Ge,, PSpC, and G,, for all the experiments are shown in Table 3 . CV (SD/mean) for the 25 replicate estimates Of PSecly Ge,, PS,,, and G,, under control conditions averaged 0.085, 0.21, 0.17, and 0.62, respectively, indicating that the uncertainty in the estimates of the endothelial parameters was approximately ~20% in most experiments. Additional uncertainty is expected if experimental measurement error is taken into account. Monte Carlo simulations showed that when the effects of realistic levels of random measurement noise were included in the analysis, uncertainty in the estimates of endothelial cell parameters increased to an average 28% (see APPENDIX).
There was greater uncertainty for the parenchymal cell parameters, in agreement with the results of the sensitivity function analysis, described in Parameter sensitivity functions.
The finding that PS,,llflow was equal to 5.3 under control conditions indicates that endothelial cell up- take of adenosine from the capillary was nearly flow limited (5), meaning that the endothelial cell membrane poses little resistance to adenosine uptake from the capillary lumen. Because it was assumed that PSeel -PS eta, G&P& + PSe,,) = 2.2, meaning that once tracer adenosine entered the endothelial cell region, it was more than twice as likely to undergo metabolism as to reflux from the cell.
The optimized value for flow in the highest-flow pathway averaged 5.9 times the mean flow (range: 4.1-9.1), and the weighting factor averaged 0.0048 (range: 0.0004-0.01). Therefore, to model the early appearance of the peak of the adenosine curve, it was sufficient to assume that 0.09% of the perfused heart mass received a blood flow that was 5.9 times the mean flow. A detailed description of the effects of heterogeneityisinthe APPENDIX.
Nitroglycerin. Adenosine dilution curves during coronary vasodilation due to nitroglycerin infusion had higher peaks than the control curves (compare Figs. 3 and 6A), although estimates of PL& and G,, were unchanged (Fig. 5, Table 3 ). The increase in the peak of (Fig. 4) . The early arrival of the peak of the adenosine curve was less pronounced during nitroglycerin infusion than under control conditions, because there was less capillary uptake of adenosine, diluting the effect of the highestflow pathways.
lodotubercidin. Intracoronary infusion of the adenosine kinase inhibitor iodotubercidin increased coronary flow to a similar extent as infusion of nitroglycerin (Table l) , so its effects on adenosine dilution curves were, in part, flow dependent. However, the increase in venous recovery of adenosine during infusion of iodotubercidin at a concentration of 10 pM (Fig. 4 ) was greater than expected on the basis of the increased flow. The effect of 3 uM iodotubercidin on adenosine recovery was intermediate between the effects of 1 and 10 uM iodotubercidin.
There was a decrease in endothelial consumption, when the iodotubercidin group as a whole (G = 5.6 ? 4.4 mlmin-l *g-l, n = 6; Table 3 ) was compared with the pooled control and nitroglycerin groups (G,, = 17 -+ 7.7 mlminlgl, n = 10; P < 0.01, two-tailed t-test), and the decrease appeared to be dose dependent (Fig. 5) .
Dipyridamole. Intracoronary infusion of the adenosine transport blocker dipyridamole at a concentration of -20 uM caused an increase in coronary blood flow (Table 1 ) and nearly complete recovery of the injected tracer adenosine in the venous samples, relative to sucrose (Fig. 4) . The adenosine curves during dipyridamole infusion were nearly superimposable with those of sucrose (Fig. 6B ), indicating that adenosine was largely restricted to the extracellular region. Confirming this interpretation was the finding that estimates of P&,1 were reduced to -5% of control values (Table 3) .
Adenosine Metabolites
During the rising portion of the adenosine dilution curves, most of the tritium in the coronary venous samples was in the form of adenosine (Fig. 7) . However, during later portions of the curve, most of the tritium was in the form of inosine, hypoxanthine, and water, produced by action of the enzymes adenosine deaminase, purine nucleoside phosphorylase, and xanthine oxidase/dehydrogenase. Tritiated water was produced as a result of tritium loss from the purine ring during the conversion of hypoxanthine to uric acid. Because tritiated 5ribose must have been formed in the production of hypoxanthine, it is possible that some of the tritium activity attributed to water may have been in the form of 5-ribose, if the membrane permeability for 5-ribose was sufficiently high. The metabolite curves were delayed relative to that of adenosine, adenosine was recovered in venous samples in the form of deamination products, whereas recovery of deamination products was 21% in the presence of 1 uM iodotubercidin (Fig. 4) . Infusion of dipyridamole caused an apparent decrease in metabolite formation, indicating negligible extracellular catabolism of adenosine in the dog heart.
Red Blood Cell Uptake ofAdenosine
Red blood cell tritium activity was measured in coronary venous blood samples collected shortly after the peak of the curves in two experiments. Tritium activity in red blood cell water (cpmml) was less than adenosine activity in plasma water in the identical samples, assuming red blood cell water content of 0.7 ml/g and plasma water content of 0.93 ml/g (Table 4 ).
Model Validation: Nontracer Adenosine Infusions
To validate the model for nontracer adenosine, five additional experiments were carried out using steadystate intracoronary adenosine infusions while measuring increased coronary blood flow and coronary venous plasma adenosine concentrations.
The rationale was to test the model by comparing model predictions of venous adenosine concentrations with measured values of venous concentrations (Fig. 8) . The model was constrained using the measurements of coronary plasma Figure  8A shows that the slope of the relation between predicted versus observed coronary venous adenosine concentrations was nearly equal to unity, 0.96 t 0.11 (mean t SE, n = 25), and the intercept was near the origin, 10 tr 20 nM, when the adenosine parameters, PS,, P&, and G,, were assigned values according to the relation between PS, and flow observed in the tracer studies (see METHODS).
Because no parameters were adjusted to improve the fit, the result indicates that there is a negligible systematic error in the model estimates of venous adenosine concentrations. The scatter is due to both methodological error and individual variation in transport parameter values among animals. Figure 8B shows that the scatter was decreased when the same results were modeled differently to decrease the effect of variability of the parameters among animals. In Fig. SB , PS, was adjusted by an average 14 -+ 11% (mean t SD, n = 5) from the values used in Fig. SA, to 
Fitting Adenosine Dilution Curves
High capillary uptake and flow heterogeneity. Fitting the adenosine dilution curves, including the early appearance of the adenosine peak, required the combination of high capillary extraction and retention of adenosine and heterogeneous flow, including a pathway with a flow of 5.9 times the mean flow under control conditions. The highest-flow pathways have the lowest PS&ow, resulting in relatively less adenosine uptake than in low-flow pathways.
Because high-flow pathways also have the earliest arrival times, they make a relatively large contribution to venous adenosine during the earliest phase of the dilution curve, but contrib- ute little at later times. This leads to an early appearance of the peak of the adenosine curve (see Fig. 10 ). High-flow pathways had little effect on the sucrose and albumin curves, because these tracers were not highly extracted and retained, as was adenosine.
Although regional flow heterogeneity was characterized using tracer microspheres in hearts of baboons (21), sheep (6), and dogs (2>, regional flow rates as high as 5.9 times the mean flow have not been routinely reported. However, fitting the adenosine curves indicates that only 0.09% of the heart is expected to have flow rates in this range, exceeding the spatial resolution of the microsphere technique. Therefore, the present findings provide better resolved constraints than previously available on the high-flow end of regional flow distributions and indicate that the degree of flow heterogeneity used in previous indicator dilution modeling (24) underrepresents somewhat the flow rates in the highest-flow pathways. The most likely reasons that early appearance of the peak of adenosine dilution curves was not observed in guinea pig heart studies (35) were that the coronary flow rates in buffer-perfused hearts were -lo-fold higher than in the blood-perfused hearts in the present study and that regional flow heterogeneity was decreased during coronary vasodilation (10,17). Red blood cell uptake. The measurements in Table 4 indicate that canine red blood cells play only a minor role in adenosine kinetics at the peak of the dilution curve. To clarify the role of red blood cells further, their effects were examined using a preliminary version of a red blood cell model of microvascular transport and exchange.
The model included two flowing regions representing red blood cells and plasma and described endothelial cell, interstitial, and parenchymal cell regions similarly as the present model. The plasma region exchanged with red blood cells, in addition to endothelial cell and interstitial regions. The red blood cell model was used to simulate the expected results wh.en the red blood cell PS was set to a realistic value giving a half time for adenosine uptake from plasma of 3 min, as observed in dog red blood cells (31). The ratio of venous red blood cell to plasma adenosine concentration in the model was 0.26 at the time corresponding to the first measurement in Table 4 , at which the ratio was 0.17-0.31.
The ratio in the model increased to 0.60 at the time of the last measurement in Table 4 , at which the ratio was 0.49-0.75. Thus the red blood cell results in Table 4 can be readily explained by the known kinetics of red blood cell adenosine exchange with plasma in the dog. It is concluded that red blood cell uptake did not cause significant error in the estimates of endothelial cell parameters.
Capillary Endothelial
Cell Uptake of Adenosine
Values of endothelial cell parameters. The values of the endothelial cell parameters for membrane transport (P&,1 = 2.87 ml l mini *g-l) and metabolic consumption capacity (G,, = 12.6 ml l rein+ g'> for the in vivo dog heart are more striking for their similarities than their differences with estimates derived for the buffer-perfused guinea pig heart [PL!& = 4.6 mlminlag-l, G,, + G,, = 55 mlmin+=g-l (35); PS ccl = 6.2 ml=min+gl, G,, -12 ml=min+~g-l(16)]. The results indicate that both dog and guinea pig hearts possess a high-capacity adenosine uptake and metabolism system on their capillary endothelium. The reason that the uptake of tracer adenosine was greater in the present study than in the guinea pig heart experiments was that coronary flow was lower in the in vivo dog hearts, resulting in higher PS,,ilflow and Ge,/flow in dog hearts than in guinea pig hearts.
Role of adenosine kinase. The capillary uptake of adenosine was mediated at least in part by the enzyme adenosine kinase, because iodotubercidin caused a decrease in G,, for adenosine. The Monte Carlo simulations showed that the effect of iodotubercidin in inhibiting adenosine kinase was probably underestimated (see APPENDIX).
Additional evidence ofthe importance of adenosine kinase was the finding that only 13% of the injected adenosine was converted to adenosine deamination products under control conditions. Although only 1% of the injected tracer adenosine appeared in coronary venous samples in the form of adenosine, endogenous coronary venous adenosine concentrations are somewhat higher than (12, 20, 23, 30) , or similar to (15), arterial concentrations in the dog. This finding can only be explained if considerable quantities of adenosine are normally produced in the heart. Therefore, there is a high turnover rate of the AMP-adenosine metabolic cycle in the normal canine heart, as was observed in the isolated guinea pig heart (25).
Estimated Nontracer Interstitial Adenosine Concentrations
The parameters determined in the present study were used in a model to estimate the steady-state relation between coronary venous plasma and interstitial concentrations of nontracer adenosine, when arterial plasma adenosine is at a constant normal concentration (45 nM) (12, 15, 20, 23, 30) and adenosine is produced at a range of rates within the cellular regions in the model (Fig. 9) . Over a lo-fold range of venous adenosine concentrations (20-200 nM) produced by increasing the modeled adenosine production, interstitial adenosine concentrations were 2.8-3.5 times higher than the corresponding venous concentrations. The relation between venous and interstitial adenosine was linear, at a constant flow. There was a crossover point in the relation at which the venous and arterial concentrations were equal (45 nM). The uncertainty in the parenchymal cell parameters had little effect on the estimates of interstitial adenosine.
Interstitial adenosine concentrations in vivo were estimated by modeling the results from previous studies in which coronary blood flow and arterial and coronary venous adenosine concentrations were measured in open-chest dogs under control conditions (Table  5 ; Refs. 12, 15, 20, 23, 30 in the range 100-220 nM, averaging 2.9-fold higher than venous plasma concentrations. Because adenosine is probably not involved in the regulation of coronary blood flow in the unstressed canine heart (13, 27), this implies that interstitial adenosine concentrations ~100 nM are in the subthreshold region of the dose-response curve for endogenous interstitial adenosine and coronary flow. Interstitial adenosine concentrations in the bloodperfused dog heart under control conditions were estimated in other studies by measuring adenosine concentrations in fluid brought into contact with the epicardial surface of the heart ("epicardial well" or "epicardial chamber" technique; Refs. 14, 18, 20) . Adenosine concentrations in epicardial well fluid were 55-80 nM (14), 250 nM (20), and 290-300 nM (I@, bracketing the estimates of interstitial adenosine of loo-220 nM in the present study (Table 5) . Advantages of the present approach are the following: 1) it may be applied in closed-chest animals; 2) temporal resolution is higher than is possible using the epicardial well; 3) the present approach provides transmural information averaged over the entire perfusion territory, whereas epicardial well methods are limited to local epicardial tissue sites; and 4) the present approach is not subject to local effects due to epicardial mesothelial cell metabolism, possible epicardial tissue injury, or epicardial nerve activity.
Present estimates of interstitial adenosine concentrations under control conditions in the blood-perfused dog heart (loo-220 nM) are higher than the estimates for isolated buffer-perfused guinea pig hearts (20) (21) (22) (23) (24) (25) Ref. 26) . The reason for the difference is that isolated hearts had -lo-fold higher coronary flow than dog hearts and fivefold higher values for PS,, describing extracellular transport between capillary and interstitial fluid via interendothelial clefts. Because of the higher parameter values in isolated hearts, washout of interstitial adenosine into the coronary venous outflow is more important than in dog hearts. Increased washout results in lower steady-state interstitial concentrations in isolated hearts than in dog hearts.
Capillary Recruitment
To model nontracer adenosine in vivo, PS,, PSecl, and G,, were treated as linear functions of flow to account for recruitment of capillary exchange surface area due to increased flow. Such an approach is not new, because Cousineau and colleagues (10) also observed increases in PS, for sucrose due to increased blood flow in the intact dog heart, which were attributed to increased capillary surface area. A simple and internally consistent approach was adopted for modeling recruitment of capillary surface area: identical fractional adjustments in the values of PS,, P&l, and G,, due to altered flow (see METHODS, Eqs. Z-4). If the density of interendothelial clefts, endothelial cell membrane adenosine transporters, and endothelial cell activities of adenosine kinase and adenosine deaminase are uniform along the capillary, then increased capillary surface area should cause equal proportional increases in the three parameters. The tracer kinetic data confirm this expectation, because the values of PS,, PSecl, and G,, observed during nitroglycerin-induced vasodilation were 1.5,1.6, and 1.6 times their control values, respectively (Tables  2 and 3) , although the increase was only significant for PS,.
Model Validation
The predictive ability of the model for nontracer adenosine was tested under conditions of intracoronary adenosine infusion by comparing model predictions of venous adenosine concentrations with direct coronary venous measurements (Fig. 8 ). When the model parameters were constrained to objectively assigned values based on pooled results from the tracer studies (Fig.  8A) , the close agreement of the linear regression line with the line of unity showed that there was no systematic bias introduced by the modeling, although variability was evident. The predictive ability was improved further by using the best values of the capillary parameters PS,, PSecl, and G,, for each individual experiment to reduce the effects of variability among animals (Fig. 8B) . The remaining variability includes methodological error from the measurements of adenosine and flow.
In conclusion, the present study provides in vivo data on the kinetics of capillary endothelial cell uptake and metabolism of adenosine and demonstrates striking single-pass extraction and retention of tracer adenosine in the canine coronary circulation. The model parameters obtained from the tracer studies may be used to estimate nontracer concentrations of interstitial adenosine from steady-state measurements of arterial and coronary venous adenosine concentrations, hematocrit, and myocardial blood flow. The model was Time,sec The early appearance of the peak of the adenosine curve may be considered using the Crone-Renkin equation, E,,, = 1 -ePpsIF, where E,,, is the peak extraction of the adenosine curve (A) relative to the reference curve [R; E(t) = 1 -hA(t)/h&)], PS is the capillary permeability-surface area product (PS, + PScl in the present study), and F is the plasma flow. The Crone-Renkin equation states that extraction of a tracer from the capillary into the tissue after an impulse injection increases exponentially with PM?. The key assumption of the Crone-Renkin equation is that there is no return flux from tissue to capillary, which is a reasonable approximation for adenosine. In a setting of multiple parallel pathways having a distribution of flows and a common input, the Crone-Renkin equation states that the pathway with the lowest extraction is the one with the highest flow (assuming PS is the same for all the pathways).
Therefore, high-flow pathways contribute most of the adenosine to the overall venous concentration and have the earliest arrival times, so their contribution is heavily weighted to the early portion of the curve. In contrast, extraction is highest in pathways with the lowest flow, because there is more time available for exchange in the capillary.
Inspection of 4 of the 20 individual weighted pathway outflow curves for sucrose and adenosine from a representative control experiment (Fig. 10) shows that these expectations are borne out. Pathway 20 had the highest flow, whereas pathway 11 had close to the mean flow. The total adenosine and sucrose curves [C,,,(t) ] are the sums of the weighted individual pathway curves (see Flow Heterogeneity). Adenosine is so strongly retained in the tissue that pathways with flow near or below the mean (pathway 11) contribute little to the total adenosine outflow curve, whereas these pathways make the greatest contribution to the total sucrose curve (because they have the highest weights and sucrose is not retained).
Although the peaks of the adenosine and sucrose curves are simultaneous in each pathway, the peak of the overall adenosine curve is dominated by the highest-flow pathways (which have the lowest extraction), whereas these pathways contribute little to the sucrose curve (because they have low weights). In this experiment, 12% of the heart mass received the flow in pathway 11, whereas only 0.4% of the heart received the flow in pathway 20. The overall result is that the peak of the total sucrose curve is broader than that of adenosine, and the peak of the total adenosine curve is earlier (see Fig. 3 ). The albumin curve shows effects similar to that of sucrose.
Reliability of Parameter Estimates
Residual analysis. The CV (SD of the residuals/mean, see METHODS) of the model fits of the dilution curves averaged 8.2 t 3.1% (mean t SD, n = 18) for albumin, 14.5 t 6.3% for sucrose, and 19.6 t 8.9% for adenosine. The residual errors of the adenosine fits, expressed as a percentage of each point along the curve, showed no significant deviations from zero (Fig. ll) parameter is the difference between the two solutions, expressed as a percentage of the value of the first solution, divided by the percentage change in the parameter, at every point in time (9). To obtain additional information on the reliability of the parameter estimates, sensitivity functions (4) of the adenosine parameters were analyzed for control conditions and nitroglycerin-induced coronary vasodilation (Fig. 12) . The top curve in Fig. 12 is the solution for the adenosine dilution curve, and the four bottom curves are the sensitivity functions. If a sensitivity function remains at zero, then it is not possible to estimate the value of the parameter. During increased flow (Fig. 12, right) , there was increased sensitivity for G,, during late portions of the dilution curve, suggesting that the estimates of G,, obtained during nitroglycerin infusion may be more informative than control estimates (Table 3) . Monte Carlo simulations.
To test the reliability of the optimizer to estimate known parameter values in the presence of random measurement error, model solutions for adenosine were generated having one output value per second, corresponding to the sampling frequency of the indicator dilution curves. Three solutions were created using adenosine parameters equal to the average values estimated for the control, nitroglycerin, and iodotubercidin experiments. Random uniform noise having a standard deviation of 20% of the model output values and a mean of zero was added to the model solutions.
The value of 20% amply represented the level of noise in the adenosine dilution curves. values by 25% or 50% in each of control (n = 4) and Nitro (n = 6) curves.
At each level of "error" in PS, and &f, adenosine curves were reoptimized, and resulting estimates of Ge, and PSe,I are shown on the ordinates.
Values of PS, and V&J with 0% error were taken from Table 2 and corresponding values of G,, and PSecl from 
